enit

Contattaci Contact Us

Home>Eventi>III International Congress on Cardiovascular Diseases

VGFM DATA-LAYER

Video & Slide

28 novembre 2023 - Giorno 1

  • SESSION I

    Relatore -

    Data Intervento 28/11/2023 - 08:45

  • Updates of the leatest ESC guidelines

    Relatore Marco Metra

    Data Intervento 28/11/2023 - 08:45

  • New trends in dyslipidemia treatment: state of the art and future developments

    Relatore Pasquale Perrone Filardi

    Data Intervento 28/11/2023 - 09:05

  • Lipoprotein (a) and cardiovascular disese: what do we know? What can we do?

    Relatore Ciro Indolfi

    Data Intervento 28/11/2023 - 09:25

  • DISCUSSION 1

    Relatore -

    Data Intervento 28/11/2023 - 09:45

  • Efficacy and Safety of Low-Dose Colchicine after myocardial Infarction

    Relatore Fausto Pinto

    Data Intervento 28/11/2023 - 10:15

  • Role of cardiac pericytes in terms of diseases and treatment

    Relatore Sanjay Kaul

    Data Intervento 28/11/2023 - 10:30

  • Redefining diabetes mellitus treatments according to different mechanisms beyond hypoglycaemic effect

    Relatore Savina Nodari

    Data Intervento 28/11/2023 - 10:50

  • DISCUSSION 2

    Relatore -

    Data Intervento 28/11/2023 - 11:10

  • The artificial intelligence in cardiology

    Relatore Mauro Pepi

    Data Intervento 28/11/2023 - 11:30

  • 3D TEE in trancatheter structural heart disease

    Relatore Francesco Faletra

    Data Intervento 28/11/2023 - 11:50

  • DISCUSSION 3

    Relatore -

    Data Intervento 28/11/2023 - 12:10

  • Tricuspid regurgitation: recent advances in understanding pathophysiology, severity grading and outcome

    Relatore Giovanni La Canna

    Data Intervento 28/11/2023 - 12:15

  • DISCUSSION 4

    Relatore -

    Data Intervento 28/11/2023 - 12:30

  • Therapeutic options in advanced heart failure

    Relatore Fausto Pinto

    Data Intervento 28/11/2023 - 12:45

  • Non reflow phenomenal: nutriment options

    Relatore Sanjiv Kaul

    Data Intervento 28/11/2023 - 13:05

  • Management of complicated pericarditis

    Relatore Massimo Imazio

    Data Intervento 28/11/2023 - 13:25

  • DISCUSSION 5

    Relatore -

    Data Intervento 28/11/2023 - 13:45

  • Best practice in coronary interventions and future perspectives

    Relatore Raffaele Piccolo

    Data Intervento 28/11/2023 - 15:00

  • Best practice in pharmacotherapy after percutaneous procedure and future perspectives

    Relatore Roxana Mehran

    Data Intervento 28/11/2023 - 15:20

  • Best practice and future perspective in structural interventions

    Relatore Marco Barbanti

    Data Intervento 28/11/2023 - 15:40

  • DISCUSSION 6

    Relatore -

    Data Intervento 28/11/2023 - 16:00

  • Why should I treat a CTO?

    Relatore Alfredo Ruggero Galassi

    Data Intervento 28/11/2023 - 16:30

  • Why should I use parenteral anti thrombotic drugs during PCI (bivalirudin, GPI, cangrelor)?

    Relatore Paolo Calabrò

    Data Intervento 28/11/2023 - 16:50

  • Why should I use intravascular imaging during PCI?

    Relatore Antonino Nicosia

    Data Intervento 28/11/2023 - 17:30

  • DISCUSSION 7

    Relatore -

    Data Intervento 28/11/2023 - 17:50

29 novembre 2023 - Giorno 2

  • Pulse field magnetic energy in atrial fibrillation ablation

    Relatore Giuseppe Schillaci

    Data Intervento 29/11/2023 - 08:45

  • High density mapping in VT ablation

    Relatore Giuseppe Sgarito

    Data Intervento 29/11/2023 - 09:15

  • The Arrythmogenic Substrate of Brugada Syndrome & LQTS: The 5th Chamber of the Heart?

    Relatore Carlo Pappone

    Data Intervento 29/11/2023 - 09:35

  • DISCUSSION 8

    Relatore -

    Data Intervento 29/11/2023 - 09:45

  • Inflammation in coronary artery disease: new perspectives

    Relatore Gianluigi Condorelli

    Data Intervento 29/11/2023 - 10:05

  • Beyond the culprit lesion: identification of high-risk vulnerable plaques and treatment strategies

    Relatore Elvin Kedhi

    Data Intervento 29/11/2023 - 10:30

  • DISCUSSION 9

    Relatore -

    Data Intervento 29/11/2023 - 10:55

  • Invasive assessment of coronary physiology in ACS: current status and future perspectives

    Relatore Emanuele Barbato

    Data Intervento 29/11/2023 - 11:10

  • New definition of asymptomatic cardiovascular toxicity: wich role for GLS?

    Relatore Antonella Moreo

    Data Intervento 29/11/2023 - 11:35

  • DISCUSSION 10

    Relatore -

    Data Intervento 29/11/2023 - 11:35

  • Prevention of coronary events in cancer patients undergoing high risk treatments : a hole in guidelines

    Relatore Javid Moslehi

    Data Intervento 29/11/2023 - 12:00

  • Endomyocardial biopsy in the clinical context: current indications

    Relatore Enrico Fabris

    Data Intervento 29/11/2023 - 12:00

  • DISCUSSION 12

    Relatore -

    Data Intervento 29/11/2023 - 12:50

  • State of the art and new perspectives treatment of the pulmonary hypertension

    Relatore Carmine Dario Vizza

    Data Intervento 29/11/2023 - 13:05

  • DISCUSSION 13

    Relatore -

    Data Intervento 29/11/2023 - 13:10

  • Cardiac magnetic resonance in hypertrophic phetotype

    Relatore Gianluca Pontone

    Data Intervento 29/11/2023 - 13:15

  • DISCUSSION 14

    Relatore -

    Data Intervento 29/11/2023 - 13:25

  • Cardio-Oncology and Cardio-Immunology: New Frontiers in Cardiovascular Medicine

    Relatore Jose Daniel JIMENEZ MARMOLEJOS

    Data Intervento 29/11/2023 - 13:35

  • DISCUSSION 15

    Relatore -

    Data Intervento 29/11/2023 - 13:45

  • The sudden death in the cardiogenetic disease

    Relatore Carlo Pappone

    Data Intervento 29/11/2023 - 14:55

  • Genetic in cardiomyopathies: when is needed?

    Relatore Francesco Mazzarotto

    Data Intervento 29/11/2023 - 15:30

  • DISCUSSION 16

    Relatore -

    Data Intervento 29/11/2023 - 16:15

  • CTA from primary prevention to guide revascularization procedures

    Relatore Gianluca Pontone

    Data Intervento 29/11/2023 - 16:40

  • Conclusion

    Relatore -

    Data Intervento 29/11/2023 - 17:20

  • Focus on what we learned and what is next in cardiovascular diseases

    Relatore -

    Data Intervento 29/11/2023 - 17:40

Area riservata

Login Annulla
 

APP FONDAZIONE MENARINI

SCOPRI L'APP


Pills of Art Menarini

“Menarini Pills of Art”
Il nuovo progetto multimediale di Menarini legato al mondo dell’arte

VISITA IL SITO


Nuovi Progetti: MINUTI DIGITALE

VISITA IL SITO


Minuti Menarini Online

Abbonati gratis alla rivista cartacea

ABBONATI GRATUITAMENTE


Fondazione Menarini



ISCRIVITI ALLA NEWSLETTER

Ricevi ogni mese le informazioni sulle attività della Fondazione Menarini.

Iscriviti

VGFM DATA-LAYER

Fondazione Menarini
Fondazione Menarini, Centro Direzionale Milanofiori 20089 Rozzano (MI) - Edificio L - Strada 6
Tel. +39 02 55308110 Fax +39 02 55305739 C.F. 94265730484